Knowledge Base Article
December 2022 Medicare Transmittals and Coverage Updates
NOTE: All in-article links open in a new tab.
December 2022 Medicare Transmittals and Coverage Updates
Published on
Wednesday, January 4, 2023
Medicare Transmittals & MLN Articles
Inpatient & Long-Term Care Hospital Prospective Payment System: FY 2023 Changes
- MLN Release Date: December 1, 2022
- What You Need to Know: This article highlights FY 2023 updates. For example, providers are reminded that CMS is not adjusting payments for any hospital in the Hospital Value Based Purchasing program or the Hospital Acquired Condition Reduction Program for FY 2023.
- MLN MM12814: (link)
DMEPOS Fee Schedule: CY 2023 Update
- MLN Release Date: December 2, 2022
- What You Need to Know: This article provides information for your billing staff about the annual update to fee schedule amounts for new and existing codes and payment policy changes.
- MLN MM13006: (link)
Clinical Laboratory Fee Schedule: CY 2023 Annual Update
- MLN Release Date: December 9, 2022
- What You Need to Know: This article provides information for your billing staff about instructions for the CY 2023 Clinical Laboratory Fee Schedule (CLFS), mapping for new codes, and updates for laboratory costs subject to the reasonable charge payment.
- MLN MM13023: (link)
HCPCS Codes & Clinical Laboratory Improvement Amendments (CLIA) Edits: April 2023
- MLN Release Date: December 9, 2022
- What You Need to Know: This article provides information for your billing staff about new HCPCS and discontinued HCPCS codes and required CLIA certificates.
- MLN MM13024: (link)
Laboratory Edit Software Changes: April 2023
- MLN Release Date: December 12, 2022
- What You Need to Know: NCDs with April 2023 updates includes 190.18 – Serum Iron Studies, 190.22 – Thyroid Testing, 190.23A – Lipids Testing, and 190.23B – Lipids Testing.
- MLN MM13026: (link)
Hospital Outpatient Prospective Payment System: January 2023 Update
- MLN Release Date: December 14, 2022
- What You Need to Know: CMS advises providers to make sure their billing staff knows about payment system updates and new codes for COVID-19, drugs, biologicals, radiopharmaceuticals, devices and other items and services.
- MLN MM13031: (link)
New Medicare Part B Immunosuppressant Drug Benefit
- MLN Release Date: December 16, 2022
- What You Need to Know: Your billing staff needs to know about the extension of Medicare coverage for immunosuppressant drugs beyond 36 months for certain patients with kidney transplants and coverage of premiums and cost sharing for these patients. This is a new benefit that was included in the Consolidated Appropriations Act (CAA) and is effective January 1, 2023.
- MLN MM12804: (link)
Ambulatory Surgical Center Payment System: January 2023 Update
- MLN Release Date: December 22, 2022
- What You Need to Know: CMS advises providers to make sure your billing staff knows about new HCPCS C-codes on the ASC Covered Procedure List (CPL), new HCPCS codes for drugs and biologics, and the skin substitute product assignments to high and low-cost groups.
- MLN MM13041: (link)
Revised Transmittals & MLN Articles
Extension of Changes to the Low-Volume Hospital Payment Adjustment and the Medicare Dependent Hospital Program
- MLN Release Date: October 21, 2022 – Revised December 9, 2022
- What You Need to Know: This article was revised due to a revised Change Request (CR) 12970. CMS will give your MAC 60 days to reprocess claims affected by the CR.
- MLN MM12970: (link)
Coverage Updates
National Coverage Determination 110.24: Chimeric Antigen Receptor T-cell Therapy
- MLN Release Date: December 1, 2022
- What You Need to Know: CMS advises providers to make sure your billing staff know about the following changes to CAR-T billing:
- Include additional place of services (POS) codes for office and independent clinics,
- Bill in 0.1-unit fractions, and
- Use 3 modifiers, including the new modifier -LU.
- MLN MM12928: (link)
- MLN Release Date: December 8, 2022
- What You Need to Know: This article provides information about FDA-approved monoclonal antibodies and CMS-approved studies that your billing staff needs to know.
- MLN MM12950: (link)
National Coverage Determination 200.3: Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease
Article Author: Beth Cobb, RN, BSN, ACM, CCDS
Beth Cobb, RN, BSN, ACM, CCDS, is the Manager of Clinical Analytics at Medical Management Plus, Inc. Beth has over twenty-five years of experience in healthcare including eleven years in Case Management at a large multi-facility health system. In her current position, Beth is a principle writer for MMP’s Wednesday@One weekly e-newsletter, an active member of our HIPAA Compliance Committee, MMP’s Education Department Program Director and co-developer of MMP’s proprietary Compliance Protection Assessment Tool.
This material was compiled to share information. MMP, Inc. is not offering legal advice. Every reasonable effort has been taken to ensure the information is accurate and useful.
Yes! Help me improve my Medicare FFS business.
Please, no soliciting.
Thank you! Someone will contact you soon.
Oops! Something went wrong while submitting the form.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
We are an environmentally conscious company, dedicated to living “green” both at work and as individuals.
© Copyright 2020 Medical Management Plus, Inc.
This website uses cookies to ensure you get the best experience. Learn More
I Accept